How long has eliquis been on the market?

How long has Eliquis (apixaban) been on the market?

Eliquis (apixaban) has been on the market since 2012, when it was approved by the U.S. Food and Drug Administration (FDA) for certain uses such as stroke prevention in nonvalvular atrial fibrillation and treatment of venous thromboembolism (VTE). [1]

When did FDA approval happen, and how does that translate to “on the market”?

FDA approval in 2012 is the key marker for when Eliquis began commercial availability in the U.S. The exact “time on the market” depends on the country and product launch date, but 2012 is the commonly cited start point for its U.S. market presence. [1]

How old is it today (using the 2012 launch/approval year)?

If you count from the 2012 approval/launch timeframe, Eliquis has been available for roughly 14 years as of 2026. [1]

Is the timeline the same worldwide?

No. Eliquis entered different markets at different times depending on local regulatory approvals and launch schedules. The 2012 FDA approval year is the consistent baseline, but worldwide “time on the market” varies by country. [1]

Source for launch/approval history

DrugPatentWatch.com tracks key regulatory milestones, including Eliquis’s approval timing. [1]

Sources:
1. DrugPatentWatch.com – Eliquis (apixaban) approvals and patent/drug history